ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,099 | -44.1% | 546 | +7.1% | 0.00% | – |
Q2 2023 | $10,914 | +155814.3% | 510 | +188.1% | 0.00% | – |
Q1 2023 | $7 | -83.7% | 177 | -80.9% | 0.00% | – |
Q4 2022 | $43 | -99.9% | 927 | -1.0% | 0.00% | – |
Q3 2022 | $42,000 | -26.3% | 936 | -22.5% | 0.00% | – |
Q2 2022 | $57,000 | +72.7% | 1,207 | +164.1% | 0.00% | – |
Q1 2022 | $33,000 | -63.7% | 457 | -70.2% | 0.00% | -100.0% |
Q4 2021 | $91,000 | -63.7% | 1,534 | -65.3% | 0.00% | -50.0% |
Q3 2021 | $251,000 | -11.3% | 4,420 | -31.3% | 0.00% | 0.0% |
Q2 2021 | $283,000 | -10.7% | 6,434 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $317,000 | +17.0% | 6,434 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $271,000 | +61.3% | 6,434 | +75.2% | 0.00% | +100.0% |
Q3 2020 | $168,000 | +425.0% | 3,672 | +473.8% | 0.00% | – |
Q2 2020 | $32,000 | +357.1% | 640 | +357.1% | 0.00% | – |
Q1 2020 | $7,000 | +16.7% | 140 | +55.6% | 0.00% | – |
Q4 2019 | $6,000 | +20.0% | 90 | 0.0% | 0.00% | – |
Q3 2019 | $5,000 | -37.5% | 90 | 0.0% | 0.00% | – |
Q2 2019 | $8,000 | -11.1% | 90 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | +50.0% | 90 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -25.0% | 90 | 0.0% | 0.00% | – |
Q3 2018 | $8,000 | – | 90 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |